Log in

NASDAQ:CRONCronos Group Stock Price, Forecast & News

$5.64
-0.23 (-3.92 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.60
Now: $5.64
$5.93
50-Day Range
$5.87
MA: $6.43
$7.08
52-Week Range
$4.00
Now: $5.64
$15.58
Volume5.97 million shs
Average Volume4.61 million shs
Market Capitalization$1.97 billion
P/E Ratio12.53
Dividend YieldN/A
Beta1.89
Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment, but does not need control. Cronos Group Inc. was incorporated in January, 2013 and is based in Toronto, Canada with an additional office in Toronto, Canada.
Read More
Cronos Group logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.34 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CRON
CUSIPN/A
CIKN/A
Phone416-504-0004

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25.64 million
Cash Flow$0.74 per share
Book Value$5.01 per share

Profitability

Net Income$1.17 billion
Net Margins1,729.07%

Miscellaneous

Employees291
Market Cap$1.97 billion
Next Earnings Date11/10/2020 (Estimated)
OptionableOptionable
$5.64
-0.23 (-3.92 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cronos Group (NASDAQ:CRON) Frequently Asked Questions

How has Cronos Group's stock been impacted by COVID-19 (Coronavirus)?

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CRON stock has increased by 4.3% and is now trading at $5.64.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Cronos Group?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cronos Group
.

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Cronos Group
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc (NASDAQ:CRON) announced its quarterly earnings data on Thursday, August, 6th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.25. The firm had revenue of $9.88 million for the quarter, compared to analyst estimates of $12.29 million. Cronos Group had a net margin of 1,729.07% and a negative return on equity of 2.56%. The business's revenue for the quarter was up 29.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.22 EPS.
View Cronos Group's earnings history
.

What price target have analysts set for CRON?

10 equities research analysts have issued 12 month price objectives for Cronos Group's stock. Their forecasts range from $6.50 to $17.00. On average, they anticipate Cronos Group's share price to reach $9.83 in the next year. This suggests a possible upside of 74.3% from the stock's current price.
View analysts' price targets for Cronos Group
.

Has Cronos Group been receiving favorable news coverage?

News articles about CRON stock have been trending extremely negative recently, according to InfoTrie. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cronos Group earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Cronos Group
.

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), NVIDIA (NVDA), Dollar Tree (DLTR), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)
  • Mr. David Hsu, Chief Operating Officer
  • Ms. Xiuming Shum, Gen. Counsel & Corp. Sec.
  • Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.
  • Mr. William Hilson, Chief Commercial Officer

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Swiss National Bank (0.23%), Virtu Financial LLC (0.06%), Wedbush Securities Inc. (0.06%), Mn Services Vermogensbeheer B.V. (0.05%), CIBC Asset Management Inc (0.03%) and Cambridge Investment Research Advisors Inc. (0.02%).

Which major investors are selling Cronos Group stock?

CRON stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Asset Management Corp IL ADV, Westside Investment Management Inc., Raymond James Financial Services Advisors Inc., and Dubuque Bank & Trust.

Which major investors are buying Cronos Group stock?

CRON stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Wedbush Securities Inc., Mn Services Vermogensbeheer B.V., Swiss National Bank, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH, Seven Eight Capital LP, UBS Group AG, and Arkfeld Wealth Strategies L.L.C..

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $5.64.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of $1.97 billion and generates $25.64 million in revenue each year. The company earns $1.17 billion in net income (profit) each year or $0.67 on an earnings per share basis. Cronos Group employs 291 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 416-504-0004.

This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.